Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-01-07 @ 2:53 AM
Study NCT ID:
NCT05949593
Status:
RECRUITING
Last Update Posted:
2025-02-14
First Post:
2023-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Sponsor:
Belite Bio, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-10
First Submit QC Date:
None
Study First Post Date:
2023-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-12
Last Update Post Date:
2025-02-14
Last Update Post Date Type:
ACTUAL